HomeAURA • NASDAQ
add
Aura Biosciences Inc
Previous close
$6.10
Day range
$6.05 - $6.73
Year range
$4.35 - $12.38
Market cap
402.75M USD
Avg Volume
225.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.04M | 30.13% |
Net income | -27.48M | -39.47% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -28.74M | -30.61% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 127.99M | -36.91% |
Total assets | 155.40M | -33.88% |
Total liabilities | 27.44M | 4.55% |
Total equity | 127.97M | — |
Shares outstanding | 50.27M | — |
Price to book | 2.39 | — |
Return on assets | -42.96% | — |
Return on capital | -45.77% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -27.48M | -39.47% |
Cash from operations | -23.36M | 4.49% |
Cash from investing | 29.81M | 217.29% |
Cash from financing | 96.00K | -62.06% |
Net change in cash | 6.53M | 144.13% |
Free cash flow | -14.30M | 17.34% |
About
Founded
2009
Headquarters
Website
Employees
106
